| Structure | Chemical Name | CAS | MF |
|
KX-01-191
|
2211903-84-1
|
C28H39N3OSn
|
|
Phosphonic acid, P-[2-[4-[bis(4-methoxyphenyl)amino]phenyl]-1-cyanoethenyl]-
|
2212003-31-9
|
C23H21N2O5P
|
|
Orforglipron
|
2212020-52-3
|
C48H48F2N10O5
|
|
(4-Fluoro-3,5-dimethylphenyl)hydrazine hydrochloride
|
2212021-40-2
|
C8H12ClFN2
|
|
1,2-Hydrazinedicarboxylic acid, 1-(4-fluoro-3,5-dimethylphenyl)-, 1,2-bis(1,1-dimethylethyl) ester
|
2212021-55-9
|
C18H27FN2O4
|
|
(2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate
|
2212021-56-0
|
C12H18N2O3
|
|
5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-amino-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)-
|
2212021-59-3
|
C20H27FN4O2
|
|
5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 3-(2,3-dihydro-2-oxo-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)-
|
2212021-61-7
|
C23H28FN5O3
|
|
Ethyl 5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-1H-indole-2-carboxylate
|
2212021-76-4
|
C18H23NO3
|
|
1H-Indole-2-carboxylic acid, 5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-, ethyl ester
|
2212021-77-5
|
C18H23NO3
|
|
1H-Indole-2-carboxylic acid, 5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-
|
2212021-78-6
|
C16H19NO3
|
|
1H-Indole-2-carboxamide, N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-
|
2212021-79-7
|
C23H26N2O2
|
|
1H-Indole-2-carboxamide, 1-(cyanomethyl)-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-
|
2212021-80-0
|
C25H27N3O2
|
|
1H-Indole-2-carboxamide, 1-[(1S,2S)-1-cyano-2-methylcyclopropyl]-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-
|
2212021-81-1
|
C28H31N3O2
|
|
5-[(S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl]-1H-indole-2-carboxylic Acid
|
2212021-83-3
|
C22H25N3O5
|
|
5H-Pyrazolo[4,3-c]pyridine-5-carboxylic acid, 2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-, 1,1-dimethylethyl ester, (4S)-
|
2212022-55-2
|
C31H33F2N7O3
|
|
2H-Imidazol-2-one, 1-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-4,5,6,7-tetrahydro-4-methyl-2H-pyrazolo[4,3-c]pyridin-3-yl]-3-(4-fluoro-1-methyl-1H-indazol-5-yl)-1,3-dihydro-
|
2212022-56-3
|
C26H25F2N7O
|
|
Orforglipron Impurity 52
|
2212022-57-4
|
C26H26ClF2N7O
|
|
2-Ethoxy-3-acetonyltaxifolin
|
2212305-01-4
|
C20H20O9
|
|
Ibrutinib Impurity 28
|
2213398-75-3
|
C18H15N5O
|
|
Florfenicol-d3
|
2213400-85-0
|
C12H11Cl2D3FNO4S
|
|
4H-1,2,4-Triazole, 4,4'-[5'-[4-(4H-1,2,4-triazol-4-yl)phenyl][1,1':3',1''-terphenyl]-4,4''-diyl]bis-
|
2213422-50-3
|
C30H21N9
|
|
Morpholine, 4-[3-(2-methyl-5-nitro-1H-imidazol-1-yl)propyl]-
|
2213449-45-5
|
C11H18N4O3
|
|
(2R,2'R,3R,3'R)-3,3'-di-tert-butyl-2,2'-di(pentan-3-yl)-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole
|
2213449-78-4
|
C32H48O2P2
|
|
3,3'-(2,6-Bis(trimethylstannyl)benzo[1,2-b:4,5-b']dithiophene-4,8-diyl)bis(9-(2-ethylhexyl)-9H-carbazole)
|
2213459-50-6
|
C56H68N2S2Sn2
|
|
IIIM-290
(IIIM290)
|
2213468-64-3
|
C23H21Cl2NO5
|
|
SR19881
|
2213490-89-0
|
C19H24N2O2
|
|
(3R,3'R)-3,3'-Bis(tert-butyl)-2,2',3,3'-tetrahydro-4,4'-bi-1,3-benzoxaphosphole
|
2214207-73-3
|
C22H28O2P2
|
|
(2R,2'R,3R,3'R)-3,3'-di-tert-butyl-2,2'-dimethyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole
|
2214207-74-4
|
C24H32O2P2
|
|
(2R,2'S,3R,3'R)-3,3'-di-tert-butyl-2,2'-diisopropyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole
|
2214207-75-5
|
C28H40O2P2
|
|
Sulpiride EP Impurity F
|
2214214-03-4
|
C15H23N3O5S
|
|
9,9'-Spirobi[9H-fluoren]-2-amine, 3-phenyl-
|
2214221-84-6
|
C31H21N
|
|
3,3'',5,5''-tetraisopropyl-[1,1':4',1''-terphenyl]-4,4''-diamine
|
2214257-62-0
|
C30H40N2
|
|
4,4'-Bis(octyloxy)-2,2'-bis(trimethylstannyl)-5,5'-bithiazole
|
2215018-37-2
|
C28H52N2O2S2Sn2
|
|
AZD8154
|
2215022-45-8
|
C27H29N5O4S2
|
|
6-Chloro-3-Iodo-1-Tetrahydropyran-2-Yl-Pyrazolo[3,4-B]Pyrazine
|
2215028-64-9
|
C10H10ClIN4O
|
|
3-(4-bromo-2-fluorophenyl)-N,N-dimethylprop-2-yn-1-amine
|
2215065-28-2
|
C11H11BrFN
|
|
3-(2-Fluoro-4-(1,2,3,6-tetrahydropyridin-4-yl)phenyl)-N,N-dimethylprop-2-yn-1-amine hydrochloride
|
2215065-31-7
|
C16H20ClFN2
|
|
Epimedonin L
|
2215102-38-6
|
C30H34O5
|
|
Interferon receptor agonist
|
2215120-36-6
|
C12H22N4O2
|
|
GSK3395879
|
2215852-91-6
|
C20H15F4N3O5S
|
|
3-(Isobutanoy)phenylboronic acid pinacol ester
|
2216004-10-1
|
C16H23BO3
|
|
Elexacaftor
|
2216712-66-0
|
C26H34F3N7O4S
|
|
4,4',4",4'"-(pyrazino[2,3-g]quinoxaline-2,3,7,8-tetrayl)tetrabenzoic acid
|
2216715-50-1
|
C38H22N4O8
|
|
2,4-Difluoro-3-cyanophenylboronic acid pinacol ester
|
2216724-47-7
|
C13H14BF2NO2
|
|
Palonosetron impurity
|
2216746-63-1
|
C18H26N2
|
|
4-Chloro-6-fluoro-7-methylquinoline
|
2216746-75-5
|
C10H7ClFN
|
|
Sacubitril Impurity 19
|
2216746-87-9
|
C22H23NO4
|
|
4-((1S)-1-AMINOETHYL)-2-METHOXYBENZOIC ACID HYDROCHLORIDE
|
2216747-15-6
|
C10H14ClNO3
|
|
Solifenacin Impurity 7(Solifenacin EP Impurity D)
|
2216750-52-4
|
C31H28N2O
|
|
2-((6-Amino-1-methyl-2-oxo-1,2-dihydroquinolin-3-yl)oxy)-N-methylacetamide
|
2216750-84-2
|
C13H15N3O3
|
|
(S)-2-Amino-3-guanidinopropanoic acid dihydrochloride
|
2216751-08-3
|
C4H11ClN4O2
|
|
5-Benzofuranacetamide, N-(4-bromo-6-methyl-2-benzothiazolyl)-2,3-dihydro-
|
2216753-63-6
|
C18H15BrN2O2S
|
|
Palonosetron Impurity 11
|
2216753-67-0
|
C18H24N2O
|
|
LYN-1604 HCl
|
2216753-86-3
|
C33H44Cl3N3O2
|
|
(2R,4S)-Isopropyl 5-([1,1''-biphenyl]-4-yl)-4-(4-isopropoxy-4-oxobutanamido)-2-methylpentanoate
|
2216755-67-6
|
C28H37NO5
|
|
Palonosetron Impurity 8
|
2216755-70-1
|
C18H26N2
|
|
Palonosetron Impurity 9
|
2216755-75-6
|
C18H24N2O
|
|
Rheb inhibitor NR1
|
2216763-38-9
|
C25H19BrCl2N2O3S
|
|
({[(2R,3S,4R,5R)-5-[2-Chloro-6-(cyclopentylamino)-9H-purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy}methyl)phosphonic acid
|
2216763-68-5
|
C16H23ClN5O7P
|
|
2'-Chloro-N6-cyclopentyl-2'-fluoro-beta-D-arabinoadenosine
|
2216764-33-7
|
C15H19ClFN5O3
|
|
Benzene, 1,1'-sulfinylbis[3-fluoro-
|
2216787-21-0
|
C12H8F2OS
|
|
Donepezil Impurity 17 HCl
|
2217617-87-1
|
C24H30ClNO5
|
|
3-chloro-1-(1,1-dimethylethyl)Naphthalene
|
2217657-09-3
|
C14H15Cl
|
|
2-(4-(tert-butyl)naphthalen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
|
2217657-10-6
|
C20H27BO2
|
|
1-bromo-7,7-dimethyl-7H-fluoreno[2,3-b]benzofuran
|
2217688-31-6
|
C21H15BrO
|
|
Pyridine, 2-(chloromethyl)-3-(1-methylethyl)-
|
2218432-57-4
|
C9H12ClN
|
|
Nintedanib-013-CO
|
2218446-42-3
|
C17H13NO4
|
|
Pyridine, 4,5-dimethyl-2-(6-methyl[1,1'-biphenyl]-3-yl)-
|
2218457-00-0
|
C20H19N
|
|
BocNH-PEG12-OH
|
2218463-36-4
|
C29H59NO14
|
|
(S)-1-(tert-butoxycarbonyl)-3-fluoropiperidine-3-carboxylic acid
|
2218467-83-3
|
C11H18FNO4
|
|
1,3,5-Triazine, 2-(3-chlorophenyl)-4-(2-dibenzofuranyl)-6-phenyl-
|
2218482-25-6
|
C27H16ClN3O
|
|
Icotinib Impurity 2
|
2218487-28-4
|
C22H21N3O6
|
|
4,4'-((5-(4-(4H-1,2,4-triazol-4-yl)phenoxy)-1,3-phenylene)bis(oxy))dibenzoic acid
|
2218519-27-6
|
C28H19N3O7
|
|
Travoprost Impurity 11
|
2218532-66-0
|
C15H16O5
|
|
[1,1'-Biphenyl]-4-carboxylic acid, (3aR,4R,5R,6aS)-hexahydro-4-(hydroxymethyl)-2-oxo-2H-cyclopenta[b]furan-5-yl ester
|
2218532-68-2
|
C21H20O5
|
|
3',4',5',6'-tetrakis(3,5-dicarboxyphenyl)-[1,1':2',1''-terphenyl]-3,3'',5,5''-tetracarboxylic acid
|
2219313-57-0
|
C54H30O24
|
|
MSC1094308
|
2219320-08-6
|
C29H29F3N2
|
|
2-Naphthaleneacetic acid, 6-[5-[[[(3,4-difluorophenyl)amino]carbonyl]amino]-2-pyrazinyl]-1,2,3,4-tetrahydro-1-oxo-2-(2,2,2-trifluoroethyl)-, (2S)-
|
2219321-25-0
|
C25H19F5N4O4
|
|
BB-Cl-Yne
|
2219324-71-5
|
C28H26ClN5O
|
|
AB-CHMICA
|
2219330-90-0
|
C21H29N3O2
|
|
BB-F-Yne
|
2219331-30-1
|
C28H26FN5O
|
|
1-(3-chlorophenyl)-4-nitrosopiperazine
|
2219339-13-4
|
C10H12ClN3O
|
|
N-Nitroso-1-(2-methoxyphenyl)-piperazine
|
2219339-64-5
|
C11H15N3O2
|
|
Pentanoic acid, 3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-4,4-dimethyl-, (3S)-
|
2219353-83-8
|
C22H25NO4
|
|
Fmoc-D-β-Homo-Cha-OH
|
2219354-02-4
|
C25H29NO4
|
|
(2R,3R)-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}-3-phenylazetidine-2-carboxylic acid
|
2219354-03-5
|
C25H21NO4
|
|
3-[3-(trifluoromethyl)-3H-diazirin-3-yl]azetidine hydrochloride
|
2219371-87-4
|
C5H7ClF3N3
|
|
3-bromo-2,4-difluoro-6-iodoaniline
|
2219373-70-1
|
C6H3BrF2IN
|
|
Apixaban Impurity 46
|
2219376-48-2
|
C11H9ClN2O3
|
|
2-chloro-3-fluoro-5-iodopyridine-4-carboxylic acid
|
2219379-36-7
|
C6H2ClFINO2
|
|
4-[3-(trifluoromethyl)-3H-diazirin-3-yl]piperidine hydrochloride
|
2219407-49-3
|
C7H11ClF3N3
|
|
Aripiprazole Impurity 27
|
2220149-92-6
|
C30H36N4O4
|
|
NMDAR antagonist 1
|
2220162-06-9
|
C20H20BrN3O2
|
|
Polymyxin B nonapeptide TFA
|
2220175-42-6
|
C45H75F3N14O13
|
|
(S)-2-(1-(6-(((6,7-difluoro-1H-benzo[d]imidazol-2-yl)methyl)amino)-9-isopropyl-9H-purin-2-yl)piperidin-2-yl)ethan-1-ol
|
2220184-50-7
|
C23H28F2N8O
|
|
3-[2-[1-(trifluoromethyl)cyclopropyl]ethoxy]-1HPyrazole-4-carboxylic acid
|
2220206-34-6
|
C10H11F3N2O3
|
|
7-O-Methylepimedonin G
|
2220243-40-1
|
C21H20O6
|
|
3"-O-Desmethylspinorhamnoside
|
2220243-41-2
|
C33H38O15
|
|
tert-butyl (3aR,5s,6aS)-5-(hydroxymethyl)hexahydrocyclopenta[c]pyrrole-2(1H)-carboxylate
|
2220998-56-9
|
C13H23NO3
|